Journal of Clinical Immunology

, Volume 36, Issue 1, pp 16–18 | Cite as

Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children

  • María Pedrosa
  • Elsa Phillips-Angles
  • Alberto López-Lera
  • Margarita López-Trascasa
  • Teresa Caballero
Letter to Editor


  1. 1.
    Caballero T, Baeza ML, Cabañas R, et al. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol. 2011;21(5):333–347; quiz follow 347.Google Scholar
  2. 2.
    Craig TJ, Aygören-Pürsün E, Bork K, et al. WAO guideline for the management of hereditary angioedema. World Allergy Organ J. 2012;5(12):182–99. doi:10.1097/WOX.0b013e318279affa.PubMedPubMedCentralCrossRefGoogle Scholar
  3. 3.
    Nielsen EW, Johansen HT, Holt J, Mollnes TE. C1 inhibitor and diagnosis of hereditary angioedema in newborns. Pediatr Res. 1994;35(2):184–7. doi:10.1203/00006450-199402000-00012.PubMedCrossRefGoogle Scholar
  4. 4.
    Grumach AS, Ceccon ME, Rutz R, Fertig A, Kirschfink M. Complement profile in neonates of different gestational ages. Scan J Immunol. 2014;79(4):276–81. doi:10.1111/sji.12154.CrossRefGoogle Scholar
  5. 5.
    Roche O, Blanch A, Duponchel C, et al. Hereditary angioedema: the mutation spectrum of SERPING1/C1NH in a large spanish cohort. Hum Mutat. 2005;26(2):135–44. doi:10.1002/humu.20197.PubMedCrossRefGoogle Scholar
  6. 6.
    López-Lera A, Garrido S, Roche O, López-Trascasa M. SERPING1 mutations in 59 families with hereditary angioedema. Mol Immunol. 2011;49(1–2):18–27. doi:10.1016/j.molimm.2011.07.010.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of AllergyHospital La Paz Institute for Health Research (IdiPAZ)MadridSpain
  2. 2.Department of ImmunologyHospital La Paz Institute for Health Research (IdiPAZ)MadridSpain
  3. 3.Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) U754MadridSpain

Personalised recommendations